Literature DB >> 24622520

Chromatin remodelling: looking vulnerable.

Nicola McCarthy.   

Abstract

Year:  2014        PMID: 24622520     DOI: 10.1038/nrc3708

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  4 in total

1.  Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers.

Authors:  Gregory R Hoffman; Rami Rahal; Frank Buxton; Kay Xiang; Gregory McAllister; Elizabeth Frias; Linda Bagdasarian; Janina Huber; Alicia Lindeman; Dongshu Chen; Rodrigo Romero; Nadire Ramadan; Tanushree Phadke; Kristy Haas; Mariela Jaskelioff; Boris G Wilson; Matthew J Meyer; Veronica Saenz-Vash; Huili Zhai; Vic E Myer; Jeffery A Porter; Nicholas Keen; Margaret E McLaughlin; Craig Mickanin; Charles W M Roberts; Frank Stegmeier; Zainab Jagani
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-11       Impact factor: 11.205

2.  MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1.

Authors:  Octavio A Romero; Manuel Torres-Diz; Eva Pros; Suvi Savola; Antonio Gomez; Sebastian Moran; Carmen Saez; Reika Iwakawa; Alberto Villanueva; Luis M Montuenga; Takashi Kohno; Jun Yokota; Montse Sanchez-Cespedes
Journal:  Cancer Discov       Date:  2013-12-20       Impact factor: 39.397

3.  Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.

Authors:  Boris G Wilson; Katherine C Helming; Xiaofeng Wang; Youngha Kim; Francisca Vazquez; Zainab Jagani; William C Hahn; Charles W M Roberts
Journal:  Mol Cell Biol       Date:  2014-01-13       Impact factor: 4.272

4.  ARID1B is a specific vulnerability in ARID1A-mutant cancers.

Authors:  Katherine C Helming; Xiaofeng Wang; Boris G Wilson; Francisca Vazquez; Jeffrey R Haswell; Haley E Manchester; Youngha Kim; Gregory V Kryukov; Mahmoud Ghandi; Andrew J Aguirre; Zainab Jagani; Zhong Wang; Levi A Garraway; William C Hahn; Charles W M Roberts
Journal:  Nat Med       Date:  2014-02-23       Impact factor: 53.440

  4 in total
  1 in total

1.  Expression inactivation of SMARCA4 by microRNAs in lung tumors.

Authors:  Isabel F Coira; Eva E Rufino-Palomares; Octavio A Romero; Paola Peinado; Chanatip Metheetrairut; Laura Boyero-Corral; Julian Carretero; Esther Farez-Vidal; Marta Cuadros; Fernando J Reyes-Zurita; Jose A Lupiáñez; Montse Sánchez-Cespedes; Frank J Slack; Pedro P Medina
Journal:  Hum Mol Genet       Date:  2014-10-29       Impact factor: 6.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.